Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 342-343
- https://doi.org/10.1016/s0041-1345(96)00300-4
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATIONTransplantation, 1993